Flavoxate: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: February 20, 2026🚩 Report this page

Flavoxate

Drugs For Urinary Frequency and Incontinence

Sold as URISPAS 200

GB MHRA

Drug class: Drugs For Urinary Frequency and Incontinence
Availability: See label
Markets covered: 1
Products on record: 5

G04BDDrugs For Urinary Frequency and Incontinence

Overview

Flavoxate is an active pharmaceutical ingredient in the Drugs For Urinary Frequency and Incontinence group (G04BD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	5	February 20, 2026

GBUnited Kingdom· MHRA

5 products

Uses

GBOfficial regulatory label· revised February 20, 2026[1]

Urispas is indicated for the symptomatic relief of dysuria, urgency, nocturia, vesical supra-pubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethro-cystitis and urethrotrigonitis. In addition, the preparation is indicated for the relief of vesico-urethral spasms due to catheterisation, cystoscopy or indwelling catheters; prior to cystoscopy or catheterisation; sequelae of surgical intervention of the lower urinary tract.

How to take

Drug interactions

Known interactions involving Flavoxate. Select one for details. This list is informational and not a complete interaction checker.

Potassium Chloride Potassium Citrate Propoxyphene Topiramate Zonisamide Acetylcholine Aclidinium Acrivastine Alfentanil Alprazolam Amantadine Ambenonium Amitriptyline Amobarbital Amoxapine Apomorphine Apraclonidine Arbutamine Aripiprazole Asenapine Atropine Azatadine Azelastine Baclofen Benzhydrocodone Bethanechol Biperiden Botulinum Toxin Type A Botulinum Toxin Type B Brexanolone Brexpiprazole Brimonidine Brivaracetam Bromocriptine Brompheniramine Buprenorphine Buspirone Butabarbital Butalbital Butorphanol Cannabidiol Carbamazepine Carbamoylcholine Carbinoxamine Cariprazine Carisoprodol Cenobamate Cetirizine Cevimeline Chlorcyclizine Chlordiazepoxide Chlormezanone Chlorphenesin Chlorpheniramine Chlorpromazine Chlorzoxazone Citalopram Clemastine Clidinium Clobazam Clomipramine Clonazepam Clonidine Clorazepate Clozapine Codeine Cyclizine Cyclobenzaprine Cyproheptadine Dantrolene Darifenacin Demecarium Desipramine Desvenlafaxine Deutetrabenazine Dexbrompheniramine Dexmedetomidine Dextromethorphan Dezocine Diazepam Dichloralphenazone Dicyclomine Dihydrocodeine Dimenhydrinate Diphenhydramine Disopyramide Donepezil Doxepin Doxylamine Dronabinol Droperidol Duloxetine Edrophonium Eluxadoline Entacapone Escitalopram Esketamine Eslicarbazepine Estazolam Eszopiclone Ethanol Ethosuximide Ethotoin Ezogabine Felbamate Fentanyl Fesoterodine Flibanserin Fluoxetine Fluphenazine Flurazepam Fluvoxamine Fosphenytoin Gabapentin Galantamine Glycopyrronium Guanidine Halazepam Haloperidol Hydrocodone Hydromorphone Hydroxyzine Hyoscyamine Iloperidone Imipramine Ipratropium Isocarboxazid Isoflurophate Ketamine Ketoconazole Lamotrigine Lasmiditan Lemborexant Levetiracetam Levocetirizine Levodopa Levorphanol Lithium Carbonate Lofexidine Loperamide Lorazepam Loxapine Lumateperone Lurasidone Maprotiline Meclizine Memantine Mepenzolate Meperidine Mephenytoin Mephobarbital Meprobamate Mesoridazine Metaxalone Methadone Methdilazine Methocarbamol Methotrimeprazine Methscopolamine Methsuximide Metoclopramide Metyrosine Midazolam Mirabegron Mirtazapine Molindone Morphine Nabilone Nalbuphine Nefazodone Neostigmine Nortriptyline Olanzapine Oliceridine Olopatadine Opicapone Opium Orphenadrine Oxazepam Oxcarbazepine Oxybutynin Oxycodone Oxymorphone Paliperidone Paraldehyde Paramethadione Paroxetine Pentazocine Pentobarbital Perampanel Pergolide Perphenazine Phenacemide Phenelzine Phenindamine Phenobarbital Phensuximide Phenylephrine Phenyltoloxamine Phenytoin Physostigmine Pilocarpine Pimozide Pramipexole Pramlintide Pregabalin Primidone Prochlorperazine Procyclidine Promazine Promethazine Propantheline Propiomazine Protriptyline Prucalopride Pyridostigmine Pyrilamine Quazepam Quetiapine Ramelteon Rasagiline Remifentanil Remimazolam Revefenacin Risperidone Rivastigmine Ropinirole Rotigotine Rufinamide Scopolamine Secobarbital Sertraline Sibutramine Solifenacin Stiripentol Sufentanil Suvorexant Tacrine Tapentadol Tasimelteon

Showing 240 of 289. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PL250460006 · revised February 20, 2026

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised February 20, 2026[1]

The source of the below ADRs frequencies is represented by data collected through clinical trials, observational studies, and spontaneous reporting. In the table below, adverse reactions are reported and listed by MedDRA system organ class and frequency: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from available data).
Within each frequency grouping the observed adverse reactions are presented in order of decreasing seriousness. System Organ Class Frequency Preferred Terms Immune system disorders Not known Hypersensitivity, anaphylactic reaction, anaphylactic shock* Psychiatric disorders Not known Confusional state* Nervous system disorders Uncommon Somnolence Eye disorders Uncommon Not known Visual impairment Glaucoma* Cardiac disorders Not known Palpitations Gastrointestinal disorders Uncommon Common Vomiting, dry mouth, dyspepsia Nausea Hepatobiliary disorders Not known Jaundice, liver disorder, hepatic enzyme abnormal* Skin and subcutaneous tissue disorders Uncommon Rare Not known Rash Urticaria, pruritus Erythema* Renal and urinary disorders Rare Urinary retention General disorders and administration site conditions Rare Fatigue *Adverse reactions from spontaneous reporting in the worldwide post-marketing experience.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. gov/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised February 20, 2026[1]

The use in children below the age of <12 years is not recommended. Since the renal clearance of the active metabolite accounts more than 50% of the dose, renal impairment may significantly affect the product kinetics. Caution is therefore required in patients with renal impairment.
Urispas contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine. Urispas contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

This is not medical advice. Consult a qualified healthcare professional.

Overview

Regulatory status by market

GBUnited Kingdom· MHRA

Drug interactions

Drugs in the same class

Sources & citations